#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Endometrial cancer Langerhans cell sarcoma Pemphigoid Thrombocytopenia Cutaneous T-cell lymphoma recurrent Mantle cell lymphoma stage III Pulmonary sarcoidosis Leiomyosarcoma Liposarcoma metastatic Plasma cell myeloma Cold type haemolytic anaemia Rhabdomyosarcoma Chronic myeloid leukaemia Cutaneous calcification More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Life with Disease Mantle cell lymphoma stage IV Progressive supranuclear palsy – Treatment Rhabdoid tumour – Life with Disease Mucopolysaccharidosis II – Trials in Disease Usher’s syndrome Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Hypereosinophilic syndrome – Life with Disease Shprintzen-Goldberg syndrome – Life with Disease Progressive multifocal leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RNMB3 89ZR-CED88004S Prednisolone Sodium Succinate Imlifidase Lovo-A Tivozanib Linsitinib Clindamycin Hydrochloride Regtivex DESMOPRESSIN ACETATE Apadamtase Alfa Diclofenac Epolamine Faricimab Tofacitinib Citrate Bezafibrate Larotrectinib Sulfate Nitrous Oxide HSP-CAR19M Oric-114 Avb-101 More therapies…

    Learn about Your Condition

    Anogenital dysplasia Pleomorphic liposarcoma Combined immunodeficiency Antithrombin III deficiency Mesothelioma Malignant neoplasm of choroid Diarrhoea Radiation skin injury Vulvovaginal candidiasis Synovial sarcoma recurrent Chondrocalcinosis Retinitis pigmentosa Diminished ovarian reserve Body mass index increased Lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Pomalidomide
    Belgium France Germany Italy Poland Portugal +1

  • Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Obinutuzumab
    • Rituximab
    Austria Belgium Czechia Denmark France Germany +6

  • A study of Pseudovax, molgramostim and tislelizumab combination therapy for patients with pseudomyxoma peritonei cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pseudomyxoma peritonei
    Investigated Drugs:
    • Molgramostim
    • Sargramostim
    • Tislelizumab
    Norway

  • Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Bevacizumab
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Testing SAR442970 compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    2 1
    Investigated Drugs:
    • Sar442970
    Belgium Czechia France Germany Poland Spain

  • Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • VHB937
    Czechia France Germany Italy The Netherlands Poland +2
Previous Page
1 … 160 161 162 163 164 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!